ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Narnatumab Biosimilar - Anti-RON Antibody - Low endotoxin, Azide free (A323597)

Recombinant mouse monoclonal antibody to RON for ELISA, FACS, Functional Assay and In Vivo.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 12-18 business days.
Name
Narnatumab Biosimilar - Anti-RON Antibody - Low endotoxin, Azide free
Description
Recombinant mouse monoclonal antibody to RON.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human
Host
Mouse
Clonality
Monoclonal
Isotype
IgG1
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 145.8 kDa.
Purity
> 95% (by SDS-PAGE).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
CD136, CDw136, Macrophage-stimulating protein receptor, MSP receptor, MST1R, p185-Ron, Protein-tyrosine kinase 8, PTK8
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Narnatumab Biosimilar - Anti-RON Antibody - Low endotoxin, Azide free (A323597)? Please let us know so that we can list the citation on this page.

Alternative products to Narnatumab Biosimilar - Anti-RON Antibody - Low endotoxin, Azide free (A323597)

Proteins predicted to interact with RON

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
93.6% Relevancy Score
87.3% Relevancy Score
86.8% Relevancy Score
84.9% Relevancy Score
81.2% Relevancy Score
79.5% Relevancy Score
75.8% Relevancy Score
75.1% Relevancy Score
74.9% Relevancy Score